Asad Moten
- Oncology top 10%
- Cancer-related Molecular Pathways 3
- Global Cancer Incidence and Screening 2
-
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
- PI3K/AKT/mTOR signaling in cancer 2
-
- Global Health and Surgery 5
-
- Cardiac, Anesthesia and Surgical Outcomes 2
-
- Economic and Financial Impacts of Cancer 2
- Co-authors
- Hui‐Kuan LinZhen CaiChia‐Hsin ChanYuan GaoChien‐Feng LiGuoxiang JinDazhi XuJohn Kenneth Morrow
- Partner nations
- United StatesTaiwanUnited Kingdom
In The Last Decade
Asad Moten
14 papers receiving 804 citations
Peers
Comparison fields: 5 of 109
- Oncology 243
- Molecular Biology 571
- Cancer Research 108
- Biomaterials 90
- Cell Biology 71
Countries citing papers authored by Asad Moten
This map shows the geographic impact of Asad Moten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asad Moten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asad Moten more than expected).
Fields of papers citing papers by Asad Moten
This network shows the impact of papers produced by Asad Moten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asad Moten. The network helps show where Asad Moten may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Asad Moten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 5 | |
| 4 | 2020 | 118 | |
| 5 | 2017 | 7 | |
| 6 | 2015 | 2 | |
| 7 | 2015 | 0 | |
| 8 | 2014 | 58 | |
| 9 | 2014 | 150 | |
| 10 | Improving cancer care in developing settings | 2014 | 1 |
| 11 | 2013 | 318 | |
| 12 | 2013 | 63 | |
| 13 | 2012 | 15 | |
| 14 | 2011 | 22 | |
| 15 | 2011 | 48 | |
| 16 | 1956 | 1 |
About Asad Moten
Asad Moten is a scholar working on Emergency Medical Services, Oncology and Anesthesiology and Pain Medicine, having authored 16 papers that have together received 821 indexed citations. Recurring topics across this work include Global Health and Surgery (5 papers), Ubiquitin and proteasome pathways (3 papers), Cancer-related Molecular Pathways (3 papers), Global Cancer Incidence and Screening (2 papers), Protein Degradation and Inhibitors (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cardiac, Anesthesia and Surgical Outcomes (2 papers) and Economic and Financial Impacts of Cancer (2 papers). The work is most often cited by research in Oncology (243 citations), Molecular Biology (571 citations) and Cancer Research (108 citations). Asad Moten has collaborated with scholars based in United States, Taiwan and United Kingdom. Frequent co-authors include Hui‐Kuan Lin, Zhen Cai, Chia‐Hsin Chan, Yuan Gao, Chien‐Feng Li, Guoxiang Jin, Dazhi Xu, John Kenneth Morrow, John E. Ladbury and Loren Stagg. Their work appears in journals such as Cell, Blood and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.